(Hypertension. 1997;30:1135-1143.)
© 1997 American Heart Association, Inc.
Articles |
Prevalence and Clinical Correlates of Microalbuminuria in Essential Hypertension
The MAGIC Study
From the Department of Internal Medicine (R.P., A.S., M.R., C.N., F.V., A.T., N.R., C.T., G.D.) and the Institute of General Pathology (G.S.), University of Genoa; and the Division of Medicine, Galliera (C.C.) and S. Martino (G.G.) Hospitals, Genoa, Italy.
Correspondence to Giacomo Deferrari, MD, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6-16132 Genoa, Italy. E-mail dimi-dir{at}unige.it
Abstract The prevalence of microalbuminuria and its relationship with several cardiovascular risk factors and target organ damage were evaluated in a cohort of 787 untreated patients with essential hypertension. Albuminuria was measured as the albumin-to-creatinine ratio in three nonconsecutive, first morning urine samples. The prevalence of microalbuminuria was 6.7%. Albuminuric patients were more likely to be men and to be characterized by higher blood pressure, body mass index, and uric acid levels and lower HDL cholesterol and HDL cholesterol-to-LDL cholesterol ratio. Piecewise linear regression analysis demonstrated that uric acid and diastolic blood pressure significantly influence albuminuria and together account for a large part of its variations. K-means cluster analysis performed on the entire cohort of patients confirmed that microalbuminuria is associated with a worse cardiovascular risk profile. Furthermore, microalbuminuria was associated with the presence of target organ damage (eg, electrocardiographic [ECG] abnormalities and retinal vascular changes). Age and the presence of microalbuminuria act as independent risk factors for the development of ECG abnormalities and retinal vascular changes. Cluster analysis allowed us to identify three subgroups of patients who differed in the presence or absence of microalbuminuria, retinopathy, and ECG abnormalities. We conclude that the prevalence of microalbuminuria in essential hypertension is lower than previously reported. Increased urinary albumin excretion is associated with a worse cardiovascular risk profile and is a concomitant indicator of early target organ damage.
Key Words: albuminuria • hypertension, essential • cardiovascular damage • risk factors
This article has been cited by other articles:
 |
|
 |
|
  M. Baekken, I. Os, L. Sandvik, and O. Oektedalen Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3130 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Leoncini, E. Ratto, F. Viazzi, V. Vaccaro, A. Parodi, V. Falqui, N. Conti, C. Tomolillo, G. Deferrari, and R. Pontremoli Increased Ambulatory Arterial Stiffness Index Is Associated With Target Organ Damage in Primary Hypertension Hypertension, September 1, 2006; 48(3): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Grosso, F Veglio, M Porta, F M Grignolo, and T Y Wong Hypertensive retinopathy revisited: some answers, more questions Br J Ophthalmol, December 1, 2005; 89(12): 1646 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-J. H van den Born, C. A A Hulsman, J. B L Hoekstra, R. O Schlingemann, and G. A van Montfrans Value of routine funduscopy in patients with hypertension: systematic review BMJ, July 9, 2005; 331(7508): 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Viazzi, D. Parodi, G. Leoncini, A. Parodi, V. Falqui, E. Ratto, S. Vettoretti, G. P. Bezante, M. Del Sette, G. Deferrari, et al. Serum Uric Acid and Target Organ Damage in Primary Hypertension Hypertension, May 1, 2005; 45(5): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Dyer, P. Greenland, P. Elliott, M. L. Daviglus, G. Claeys, H. Kesteloot, H. Ueshima, J. Stamler, and for the INTERMAP Research Group Evaluation of Measures of Urinary Albumin Excretion in Epidemiologic Studies Am. J. Epidemiol., December 1, 2004; 160(11): 1122 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Leoncini, F. Viazzi, D. Parodi, E. Ratto, S. Vettoretti, V. Vaccaro, M. Ravera, G. Deferrari, and R. Pontremoli Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S88 - 90. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Romundstad, J. Holmen, H. Hallan, K. Kvenild, and H. Ellekjaer Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals: Does Sex Matter?: The Nord-Trondelag Health Study (HUNT), Norway Circulation, December 2, 2003; 108(22): 2783 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
|
|
G. Leoncini, F. Viazzi, D. Parodi, S. Vettoretti, E. Ratto, M. Ravera, C. Tomolillo, M. Del Sette, G. P. Bezante, G. Deferrari, et al. Mild Renal Dysfunction and Subclinical Cardiovascular Damage in Primary Hypertension Hypertension, July 1, 2003; 42(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pontremoli, G. Leoncini, M. Ravera, F. Viazzi, S. Vettoretti, E. Ratto, D. Parodi, C. Tomolillo, and G. Deferrari Microalbuminuria, Cardiovascular, and Renal Risk in Primary Hypertension J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S169 - 172. [Abstract] [Full Text]
|
|
|
|
|
|
F. Viazzi, G. Leoncini, D. Parodi, M. Ravera, E. Ratto, S. Vettoretti, C. Tomolillo, M. D. Sette, G. P. Bezante, G. Deferrari, et al. Pulse pressure and subclinical cardiovascular damage in primary hypertension Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1779 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Mattix, C.-y. Hsu, S. Shaykevich, and G. Curhan Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1034 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Garg and G. L Bakris Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vascular Medicine, February 1, 2002; 7(1): 35 - 43. [Abstract] [PDF]
|
|
|
|
|
|
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johnsen Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease Hypertension, April 1, 2000; 35(4): 898 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yavuz, A. Toprak, Y. Budak, H. O. Ersoz, O. Deyneli, H. Tezcan, and S. Akalin Urinary Glycosaminoglycan Excretion in Newly Diagnosed Essential Hypertensive Patients Clin. Chem., February 1, 2000; 46(2): 299 - 301. [Full Text] [PDF]
|
|